6796
K.-C. Lee et al. / Bioorg. Med. Chem. Lett. 20 (2010) 6794–6796
zones. Thus hydrophobicity of the aryl or alkyl group on hydrazine
of thiosemicarbazones is determinant factor for their inhibitory
activity in melanogenesis rather than planarity.
S
H
N
N
NH2
N
H
NH2
N
S
2a, IC50 >10 µM,
C log P = 1.865
Acknowledgments
2q, IC50 = 1.1 µM,
C log P = 3.039
This work was supported by a grant (R01-2007-000-20099-0)
and Priority Research Centers Program (2009-0093815) through
the National Research Foundation of Korea (NRF) funded by the
Ministry of Education, Science and Technology.
lncreament of
liphophilicity
poor transfer
good transfer
Supplementary data
Figure 1. The correlation of inhibitory activity of 2a and 2q with their liphophilicity
on melanoma B16 cell membrane.
Supplementary data associated with this article can be found, in
size. In addition, the naphthyl group also increases the hydropho-
bicity. Thus to confirm the necessity of aromatic group, phenyl
group of 2a was replaced with bulky cyclohexyl group as shown
References and notes
1. Sánchez-Ferrer, A.; Rodríguez-López, J. N.; García-Cánovas, F.; García-Carmona,
F. Biochim. Biophys. Acta 1995, 1247, 1.
in 2r (81% inhibition at 10 lM, IC50 = 3.4 lM, C log P = 1.987),
which also exhibited a strong inhibition. This proves that the aro-
matic planarity is not important at this position. Thus, the
enhancement of activity in naphthyl analog 2q should result from
its increased hydrophobicity. Therefore, we can conclude that
hydrophobicity of the substituent on hydrazine of thiosemicarba-
zones is more important factor for the inhibitory activity in mela-
nogenesis rather than the planarity. Moreover, complete loss of
2. Chase, M. R.; Raina, K.; Bruno, J.; Sugumaran, M. Insect Biochem. Mol. 2000, 30,
953.
3. Hearing, V. J.; Jimenez, M. Int. J. Biochem. 1987, 19, 1141.
4. Halaban, R.; Patton, R. S.; Cheng, E.; Svedine, S.; Trombetta, E. S.; Wahl, M. L.;
Ariyan, S.; Hebert, D. N. J. Biol. Chem. 2002, 277, 14821.
5. Xu, Y.; Stokes, A. H.; Roskosi, R. J.; Vrana, K. E. J. Neurosci. Res. 1998, 54,
691.
6. Asanuma, M.; Miyazaki, I.; Ogawa, N. Neurotoxicol. Res. 2003, 5, 165.
7. Oetting, W. S. Pigment Cell Res. 2000, 13, 320.
activity in pyridine analog 2s (15% inhibition at 10
lM,
8. Ashida, M.; Brey, P. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 10698.
9. Fitzpatrick, T. B.; Eisen, A. Z.; Wolff, K.; Freedberg, I. M.; Austen, K. F.
Dermatology in General Medicine; McGraw-Hill, Inc., New York, NY, 1983.
10. Maeda, K.; Fukuda, M. J. Soc. Cosmet. Chem. 1991, 42, 361.
11. Kojima, S.; Yamaguchi, H.; Morita, K.; Ueno, Y. Biol. Pharm. Bull. 1995, 18, 1076.
12. Verallo-Rowell, V. M.; Verallo, V.; Graupe, K.; Lopez-Villafuerte, L.; Garcia-
Lopez, M. Acta Derm. Venereol. 1989, 143, 58.
IC50 >30 M, C log P = 1.088) strengthens our viewpoint on the
l
importance of hydrophobicity rather than hydrophilicity or
planarity.
Noticeably, the importance of hydrophobicity becomes more
obvious when comparing the C log P values of 2a–s. For instance,
a simple benzaldehyde thiosemicarbazone (2a, <10% inhibition at
13. Takiwake, H.; Shirai, S.; Kohono, H.; Soh, H.; Arase, S. J. Invest. Dermatol. 1994,
103, 642.
10
l
M, IC50 >10
l
M, C log P = 1.865) has been well known tyrosi-
M, but it did not show
14. Kimbrough-Green, C. K. Arch. Dermatol. 1994, 130, 727.
15. DuBois, K. P.; Erway, W. F. J. Biol. Chem. 1946, 165, 711.
16. Criton, M.; Le Mallay-Harmon, V. Bioorg. Med. Chem. Lett. 2008, 18, 3607.
17. Gerdemann, C.; Eicken, C.; Krebs, B. Acc. Chem. Res. 2002, 35, 183.
18. Klabunde, T.; Eicken, C.; Sacchettini, J. C.; Krebs, B. Nat. Struct. Biol. 1998, 5,
1084.
19. Lv, P. C.; Zhou, C. F.; Chen, J.; Liu, P. G.; Wang, K. R.; Mao, W. J.; Li, H. Q.; Yang,
Y.; Xiong, J.; Zhu, H. L. Bioorg. Med. Chem. 2010, 18, 314.
20. Thanigaimalai, P.; Le Hoang, T. A.; Lee, K. C.; Bang, S. C.; Sharma, V. K.; Yun, C.
Y.; Roh, E.; Hwang, B. Y.; Kim, Y.; Jung, S. H. Bioorg. Med. Chem. Lett. 2010, 20,
2991.
nase inhibitor27 with the IC50 value of 1.93
l
any notable inhibition in our melanoma B16 cell based bioassay
because it may not have enough liphophilicity to penetrate the cell
(Fig. 1). Hydroxyl derivatives 2g, 2k, and 2p showed poor activity
with the same reason. However, the naphthyl analog 2q (>100%
inhibition at 10 lM, IC50 = 1.1 lM, C log P = 3.039) and other ana-
logs of 2, containing hydrophobic substituent’s showed an excel-
lent inhibitory activity compared to 2a. Thus, the hydrophobic or
bulky groups are important for the effective inhibition of melano-
genesis in B16 cells.
21. Varsha, J.; Pradeep, M.; Sushil, K.; Stables, J. P. Eur. J. Med. Chem. 2008, 43,
135.
22. Xie, X. Y.; Jiang, L.; Xue, C. B.; Luo, W. C. Huaxue Shiji 2007, 29, 34.
23. Jatav, V.; Kashaw, S.; Mishra, P. Med. Chem. Res. 2008, 17, 169.
24. Wuyts, H.; Berman, L.; Lacourt, A. Bull. Soc. Chimiques Belg. 1931, 40, 665.
25. Karki, S. S.; Thota, S.; Darj, S. Y.; Balzarini, J.; De Clercq, E. Bioorg. Med. Chem.
2007, 15, 6632.
26. Bakkar, M. S.; Yamin, M.; Monshi, M. S. Synth. React. Inorg. Met.-Org. Chem.
2003, 33, 1157.
27. Yi, W.; Cao, R. H.; Chen, Z. Y.; Yu, L.; Ma, L.; Song, H. C. Chem. Pharm. Bull. 2009,
57, 1273.
In conclusion, we have design, synthesized and tested a series of
thiosemicarbazones 2(e–s) as inhibitors of melanogenesis for
defining their structure–activity relationship (SAR) studies. As a re-
sult (Z)-2-(naphthalen-1-ylmethylene)hydrazinecarbothioamide
(2q) proved the best melanogenesis inhibitor among synthesized
compounds. Regarding SAR, we observed the two important points.
Substituent’s with highly hydrophobic property regardless the po-
sition of phenyl ring of the thiosemicarbazones is more important
for enhancement of the activity than the hydrophilic one. In addi-
tion, the aromatic group of thiosemicarbazones can be replaced
with sterically bulky carbocycles. Unlike PTU derivatives, steric
bulkiness does not hamper the activity of these thiosemicarba-
28. Brahmeshwari, G.; Rao, V. R.; Kumari, T. S.; Rao, T. V. P. Phosphorus, Sulfur
Silicon Relat. Elem. 1994, 92, 51.
29. Li, M.; Yao, L.; Wang, Z.; Wang, J. Huaxue Yanjiu 2006, 17, 44.
30. Thanigaimalai, P.; Lee, K. C.; Bang, S. C.; Lee, J. H.; Yun, C. Y.; Roh, E.; Hwang, B.
Y.; Kim, Y.; Jung, S. H. Bioorg. Med. Chem. 2010, 18, 1135.
31. Xue, C. B.; Zhang, L.; Luo, W. C.; Xie, X. Y.; Jiang, L.; Xiao, T. Bioorg. Med. Chem.
2007, 15, 2006.